Category Archives: Online

From Universal HIV Testing to HIV Cure

People involved in the fight against HIV/AIDS will gather in Marseille, France, May 23-25, 2012 for an international AIDS Conference under the theme: ‘From Universal HIV Testing to HIV Cure’.

The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is a major scientific event attracting doctors, biologists, researchers, patients’ representatives and policy makers from all around the world. Its next edition, to be held just more than one year ahead, will focus on recent developments against this pandemic.

Despite major advances in antiretroviral therapy, HIV still infects daily 2,000 new individuals and kills 2 millions each year. Current treatments are life-long with problems of compliance, resistance, toxicity, access, and cost.

‘There are advances both in the area of prevention, testing and potential cure’ told Alain Lafeuillade, a French Doctor involved in the organization of the conference. ‘Our driving force is to draw to the conference the best experts in the world for each program theme’. Antiretroviral treatment as prevention (or pre-exposure prophylaxis) will be debated with the pros and cons. Human rights and access to HIV care will be the focus of en entire session. Current issues in antiretroviral therapy management will be discussed during 2 sessions. Finally, the best American experts in the field of HIV reservoirs and eradication research will present their latest discoveries in the search for a cure.

The international Steering Committee will actively build a program the most exciting possible in the forthcoming months. Meanwhile, interviews of renowned experts are regularly published on the meeting website: http://www.isheid.com/en/committees/interview.html

Via EPR Network
More Healthcare press releases

New Website Dedicated To Stem Cell Investors

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases

Depuy Pinnacle Hip Replacement Helpline Launched To Assist Victims Of Faulty Hip Replacements

Jewish Lawyers Network has launched a hip replacement helpline. According to Lisa Spitzer MSW,” these faulty hip replacements affect seniors at a time in their lives when quality of life and independence are crucial factors” “Any surgery takes longer to recover from. The psychological and physical effects put seniors back months”. ” Having to go through additional pain and surgeries can lead to severe depression and a downhill process”.

In the months since a recall of the DePuy ASR XL artificial hip, DePuy might be facing the recall of yet another one of its hip replacements, the Pinnacle Acetabular Component, which has been facing increased scrutiny for its premature failures.

Like the ASR XL, the Depuy Pinnacle is a metal on metal system that was designed to last at least 10-15 years but now, orthopedic surgeons are reporting that these devices have been failing within one to two years of being implanted into their patients.

That’s not good news for DePuy, a division of Johnson & Johnson, which has implanted over 150,000 Pinnacle hip replacements into patients since it was put into service in 2001. Its recent recall of the defective ASR metal-on-metal hip implant systems has forced thousands of hip implant patients to have additional, painful and expensive hip revision surgeries. This effects seniors the most. All surgeries at that age are traumatic with extensive recovery time and rehabilitation. After the surgery, the patient, can spend weeks in a rehabilitation facility away from family, friends and routine. This isolation can effect mood. After discharge there is usually weeks of in home rehabilitation. Going through this once, according to Spitzer, is traumatic, We do not know how many seniors can actually go through this twice and regain the pre-surgery level of functioning. Spitzer feels this will not only affect an individuals quality of life but perhaps even life span, depending on age and other health factors. “If a senior has kept going, for instance, by play golf every day with friends and he or she loses this, it could be a downhill road” You may contact the helpline by calling 1 877-522-2123.

Although the ASR and Pinnacle are both metal on metal systems, there are significant differences between the two insofar as:
* the ASR is a monoblock design whereas the Pinnacle uses a modular system.
* the ASR cup is made of one solid piece of metal whereas the Pinnacle has an outer shell
* The Pinnacle is designed in such a way that the surgeon has the option to place a metal, ceramic or polyethylene liner inside the metal outer cup

Much of the problem seems to be with the Pinnacle 36 mm Ultamet Metal-on-Metal component which is failing at an unacceptably high rate. One of the theories seeking to determine the cause suggests that a design problem flows from the fact that the device has been created with one of the lowest clearance levels in the industry. The only other implant with a clearance level this low is the DePuy ASR.

Attorneys and experts investigating the basis for the high rate of failure point to the product design and believe that DePuy created a very narrow window for proper placement of the prosthesis and inadequately trained surgeons in the proper implantation technique.

Like, the recalled DePuy ASR system, the Pinnacle was permitted to reach the market under the U.S. Food and Drug Administration’s (FDA) controversial 510(k) approval process, which allows a medical device to be placed on the market without being subjected to necessary clinical trials as long as the manufacturer can show that the device is “substantially equivalent” to a device already approved on the market. DePuy’s ASR system avoided obligatory clinical trials by showing that it was fundamentally similar to the DePuy Pinnacle hip replacement system, raising some serious issues.

Recently, the FDA has received hundreds of complaints and adverse incident reports against the Pinnacle system, attributed mostly to the Pinnacle’s propensity to prematurely separate from the bone. Moreover, like many other metal on metal devices, constant friction in the Pinnacle may cause an increased risk of metallosis, i.e. the release of miniscule metal particles into the surrounding soft tissue or bloodstream.

All of this has resulted in a wave of new lawsuits being filed around the country against DePuy. Just last week, a motion was filed in the United States District Court in California seeking to consolidate all DePuy Pinnacle cases before one judge in what is known as a multi- district litigation, or MDL. The MDL Panel is scheduled to rule on this application in May.

Via EPR Network
More Healthcare press releases

Medical Innovation Protection Stressed in EU-India Free Trade Agreement Talks

The Financial Express published an article on the Free Trade Agreement (FTA) talks that continue between the European Union (EU) and India. One of the most discussed and disagreed upon parts of the proposed FTA involves the need for protecting the intellectual property of pharmaceutical companies in order to promote medical innovation and investment in the development of new medicines and research. This disagreement about whether data exclusivity in the pharmaceutical sector should be included has resulted in the delay of finalizing the FTA.

Pharmaceutical companies rely on data exclusivity to protect the investment made in developing the medication that is used throughout the world. Millions of dollars are spent on clinical trials to prove the safety and effectiveness of these drugs. These exclusive rights prevent competitors from obtaining marketing licenses for lower cost versions of these drugs.

Global Health Progress (GHP) is committed to being part of the effort to create a sustainable health care system that includes improving access to health care and continuing medical innovation and progress for all people. While the pharma industry is divided on the issue, GHP supports efforts to improve regulations protecting pharmaceutical companies’ intellectual property. Without this protection, the funding of studies that bring these medications to market could suffer.

Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.

www.globalhealthprogress.org;

twitter.com/globalhealth;

facebook.com/pages/Global-Health-Progress/124850684219049;

linkedin.com/groups?home=&gid=2972068

Via EPR Network
More Healthcare press releases

Global Health Progress Amplifies Report Calling for Funding Products to Fight Neglected Tropical Diseases

The third-annual Global Funding of Innovation for Neglected Diseases (G-FINDER) survey was released last week revealing both good and bad news for the funding of neglected diseases in the developing world. In a press release issued by Policy Cures, an independent group providing research and analysis for those involved in the creation of new pharmaceuticals for neglected diseases, the group reveals that while funding for neglected diseases has increased, funding for new products has decreased.

Funders appear to be focusing more of their money toward traditional basic research. This shift has caused a $50 million drop in funding for Product Development Partnerships (PDP), non-profit organizations that partner with external organizations to drive product development for neglected diseases, including neglected tropical diseases.

Report author Dr Mary Moran, Director of Policy Cures warns funders not to “take their eyes off the ball” in the press release, stating that while the increase in funding is encouraging it is important that the funds are spent wisely.

Global Health Progress has worked with partner groups to encourage and sustain funding for the research and development of new products. The innovative research and development (R&D) of new drugs and vaccines is a critical component of improving health care and combating epidemics of neglected tropical diseases in developing countries. There are no vaccines or cures for some widespread and life threatening diseases such as malaria, while existing treatments for diseases such as tuberculosis are becoming less effective due to drug resistance.

Read the full press release from Policy Cures here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/G-FINDER_Year_3_media_release.pdf,
or read the G-FINDER report on the Policy Cures website:
http://www.policycures.org/downloads/g-finder_2010.pdf.

Via EPR Network
More Healthcare press releases

Big Mountain Pharmacy Launches a New Blog: Blogging the Drugs

One thing that has often been lacking from online Canadian pharmacies is information. Not only about the drugs on sale themselves, but also about illnesses and general news on the medical industry such as regulation and equipment.

That is what triggered Big Mountain Drugs to start their health information blog, which is now fully up and running on their website offering articles packed with information about common illnesses such as Alzheimer’s, erectile dysfunction (impotence) and acne. Not only that, they have also released articles giving useful information to help with particularly common issues. These include helping patients with poor eyesight by giving tips on how to identify medication safely, and giving family and friends of patients’ advice on how to tell the difference between dementia and depression.

Information like this is extremely valuable to patients, as they can learn more about the drugs that they are taking and the conditions that they are taking them for. The knowledge to patients increases safety as they can easily spot the symptoms of complex or potentially dangerous illnesses, and learn how to deal with the issues that come with many conditions. Blogging the Drugs from Big Mountain pharmacy, which can be found on their website, now lists many informative articles to help their customers. All of the information is free, and is written by medical professionals giving accurate and interesting information and facts.

One customer said: “Blogging the Drugs from Big Mountain pharmacy is extremely helpful and I’ve discovered a lot of new things about my illness that I didn’t know before, including information about the drugs that I am taking so that I can keep an eye out for side effects. It makes me feel much safer that I have more knowledge than I did before”.

Big Mountain Drugs commented “We wanted to add value to our customers by allowing them to make more informed decisions. Although they cannot buy most of the drugs without a prescription, it still gives them the opportunity to learn about the drugs that they are prescribed by their doctor so that they can speak with their doctor if they have any concerns. It also helps them to learn about their illnesses so that they can be aware of any issues such as symptoms of their conditions”.

One concern however, is that online Canadian pharmacies as of recent times, are no longer allowed to advertise on Google unless it is in their own country, which will mean that many people searching for information on drugs online will not be able to find the blog unless they live in Canada if they use Google to search for it.

You can join the blog on Facebook (bigmountaindrugs) and Twitter (bigmountaindrug), some of the most popular social networking sites so it is always very easy to connect and check out any new information that is issued by Big Mountain Drugs. They also post videos on Youtube and you can subscribe by RSS feed so that you get information in new articles as soon as they are posted online.

Via EPR Network
More Healthcare press releases

Online voucher codes specialist delivers fitness incentives to Brits with new deals

It is the time of year when people turn their thoughts to getting fit or losing weight in time for a summer holiday, and to help them do so on a budget, DiscountVouchers.co.uk has new deals available. The specialist voucher codes site has offers on show to save at LA Fitness and WeightWatchers.

Gym memberships can be an expensive thing, but right now DiscountVouchers.co.uk is offering people cheap deals for top UK gym chain LA Fitness. The latest LA Fitness offers available online include a deal for no joining fee, no contract – perfect for encouraging people to get out and use the gym to get fit.

On top of the membership offer, the LA Fitness deals available online also cover trial deals and clothing. TheDiscountVouchers.co.uk site is now home to an offer giving 9 weeks peak membership for just £99 – perfect for trying the gym before signing up as a long-term member. The online deals specialist is also offering money off fitness clothing and kit from leading brands like Adidas, Rohnisch and Shock Absorber.

Losing weight is not the easiest thing in the world for most people, but to encourage them to make a start DiscountVouchers.co.uk is offering new WeightWatchers discount codes. The site is right now home to a deal for free membership to help people save themselves the £33.95 membership fee as an incentive.

Simon Terry, spokesperson for DiscountVouchers.co.uk, comments, “Getting oneself into shape ahead of a summer holiday to the beach is a common practice, and we can help people save on this habit this year. Money off top brands including LA Fitness and Weightwatchers can be a real bonus to people in helping them make a start on getting into shape.”

DiscountVouchers.co.uk offers people money saving deals at both major high street brands and specialist retailers, including stores like Tesco, Marks & Spencer, Sainsbury’s, Travelodge, First Choice, lastminute.com and Boden.

Via EPR Network
More Healthcare press releases

South Beach Diet Adviser Launches Free Diet Website

A new and innovative diet website has been launched at southbeach-diet-adviser.com offering free diet advice and weight loss tips for anyone interested in the innovative diet plan. The comprehensive site is a cost free introduction to the popular South Beach Diet and includes extensive information on how the diet works as well as helpful tips, recipes and an interactive forum for dieters.

The editors of South Beach Diet Adviser explain, “We checked out a variety of diet and weight loss plans and were most impressed with the South Beach plan. It’s easy to follow and features a wide variety of foods, so almost anyone can do it. We realized that by establishing a free website, we could help millions of people lose weight and keep it off without having to pay a lot of money. Our research indicated that this plan is ideal for anyone who wants to not only lose weight, but who wants to keep it off.”

Weight Loss Without Extra Costs

The website features a variety of helpful articles, including a detailed shopping guide dieters can use to stock their pantries and refrigerators with foods that are allowed during each of the three phases of the South Beach Diet. Detailed information on the three phases of the diet make it easy to understand how the program works and what kind of results an individual can expect as they lose weight. Meal plans, recipes, and reviews of books about the program make it easy to not only stick to the diet, but choose the right tools for your own weight loss program.

Links to the official South Beach Diet website and other sites offering packaged meal supplements and snacks are also on the new website. These give dieters the option to enroll in paid programs or order prepared convenience foods, although the many free recipes and diet tips at the Adviser are more than enough to keep most dieters on track without spending a dime.

Flexibility and Success for Free

The editors at South Beach Diet Adviser note that the flexibility of the popular diet system is what makes it so successful. There are no calories to count or points to keep track of, making it the ideal diet for today’s busy dieters. Three distinct phases help dieters jump start their weight loss, continue losing pounds at a healthy rate, and maintain their weight through a lifetime of healthy choices. If you’re interested in losing weight and keeping it off for free, no obligation guidance and support is available at southbeach-diet-adviser.com.

About South Beach Diet Adviser:
The editors at  southbeach-diet-adviser.com have compiled an extensive library of information on the South Beach Diet plan, including weight loss tips, a grocery guide, and detailed plans for losing weight and keeping it off. They are proud to offer open forums, detailed information on the glycemic index, and helpful tools at no cost to users so that anyone can use the plan successfully.

Via EPR Network
More Healthcare press releases

Global Health Progress Encourages Global Partnerships on Access to Health Care

Starting this month, members of Congress will be looking closely at U.S. spending as they work with the White House to build the 2012 budget. One area that has come under increased scrutiny is U.S. spending on global health programs. Several groups last week announced a petition (http://www.supportglobalhealth.org/) seeking support for global health spending through the United States Global Health Initiative. Many fear that even flat spending in this area could jeopardize important programs in vaccine research and treatment.

News like this highlights the important role that public-private partnerships play in supporting access to global health care. The Global Health Progress initiative seeks to bring research-based biopharmaceutical companies and global health leaders together to improve access to medicine and health care in the developing world. We are committed to being part of the effort to create a sustainable health care system that includes improving access to health care and continuing medical innovation and progress for all people.

Research-based biopharmaceutical companies and their partners around the world are working to implement sustainable solutions and strengthen the health care delivery systems so they can meet tomorrow’s challenges. Millions of people lack access to essential medicines due to factors including incomplete delivery systems, lack of training for health personnel, lack of infrastructure and the cost of treatments. We must address the underlying barriers to health care, such as weak and fragmented health systems, limited health care personnel and inadequate resources for scaling up proven solutions. The innovative research and development (R&D) of new drugs and vaccines is a critical component of improving health care and combating epidemics in developing countries.

Through meaningful public-private partnerships with others in the field, including policymakers in the developed and developing world, multi-lateral institutions, non-governmental organizations, and academia we can help shape sustainable solutions that improve the health of all people.

To stay informed on the latest news about global investment in pharmaceutical R&D and improving access to medicines, sign up to receive special alerts and newsletters. You can also spread the word about the efforts of the Global Health Progress initiative and keep others informed about how we’re affecting change around the world, or share your story about how you or someone you know is working to promote global health.

Via EPR Network
More Healthcare press releases

Physiotherapy Store Offer Live Advice to Patients Online

Physiotherapystore.com, one of the UK’s largest online suppliers of specialist physiotherapy products, has launched an online, live chat service for its customers.

The live chat service, called ‘Live Support Online’, allows customers to talk to the company’s customer service and sales staff about the products available to buy online. The new facility means that customers can now contact a Physiotherapystore representative by phone, e-mail or Live Chat depending on which method they prefer and be completely confident that they are choosing the best product, before they commit to buying.

Customers can access Live Support Online from the home page, entering their name and question to start the chat. Staff will respond as quickly as possible with detailed yet concise information that will help to direct the customer towards suitable products, such as orthopaedic supports and items from the best-selling Biofreeze and Clinell Products range.

Physiotherapystore.com already offers interactive services to customers, but wanted to increase the help available, to ensure that common injuries, aches, and pains, are treated with the right products.

“Launching Live Support Online was the next logical step for us – we can now share our product knowledge with customers online, as well as via the telephone”, said Gary Shawcross, Director of Physiotherapystore.com

As well as the online chat service, customers can click on different areas of the body, on a picture of the human form, to find information on common injuries and ailments and to be taken to treatments and supports within that category.

Via EPR Network
More Healthcare press releases

Assay-Ready Chemistry Partnership between Molplex & Enamine

Molplex and Enamine today announced a new partnership to offer the Enamine screening collection of 1.8 million stock chemicals through the Molplex online drug design and assay-ready chemical supply services. The agreement is a major step towards eliminating the high start-up costs ofdrug discovery, bringing sophisticated drug design, compound management and assay-ready chemistry to the world’s drug discovery scientists on demand.

The agreement adds Molplex online drug design systems to the deep experience in organic chemistry and compound management of Enamine to solve the problem of generating viable chemical leads for novel targets.

Molplex CEO David E. Leahy said: “We are very proud to be selected by Enamine as their partner for on demand drug discovery services at a time when major restructuring of the industry is creating new opportunities and new markets for our combined expertise. This agreement marks a step change in the size and scope of our assay-ready chemical supply service and major progress towards our goal of being the world’s first choice partner for enabling the long tail of drug discovery”

Via EPR Network
More Healthcare press releases

New UN Program Will Ensure Developing Nations Continue to Have Access to Drugs Effective At Treating Malaria

Earlier this week, the United Nations announced a new plan of action designed to help fight disease resistance to artemisinin, the world’s most potent treatment for malaria. Launched by the UN World Health Organization (WHO) and the Roll Back Malaria Partnership (RBM), the groups hope to better contain and prevent resistance to artemisinins, the critical component of artemisinin-based combination therapies (ACTs), which are currently the most effective weapon in treating falciparum malaria.

The WHO’s announcement describes the plan as a five-step process which “aims to contain and prevent artemisinin resistance by stopping the spread of resistant parasites, increase monitoring and surveillance for artemisinin resistance, improve access to malaria diagnostic testing and rational treatment with ACTs, invest in artemisinin resistance-related research, and motivate action and mobilize resources.”

Global Health Progress is hopeful that this action plan will help to ensure that developing nations continue to have access to drugs that most effectively treat malaria. Many malaria-stricken countries lack the resources needed to keep an effective health care system running smoothly. Strong, effective health systems are vital to helping those in need of access to drugs, and health care improvements made today will strengthen the ability of countries to develop sustainable systems that can meet tomorrow’s challenges. Stopping the spread of drug-resistant strains of malaria and other diseases are essential to these goals.

Investing in local R&D capacity and national research systems is another way research-based biopharmaceutical companies help strengthen health systems. Local production can play a valuable role in building overall local capacity and enabling developing countries to increase access to essential medicines.

It is the responsibility of the entire international community to facilitate access to medicines. Success depends on all sectors working in partnership; not only to make medicines more accessible, but also to ensure continued innovation into new medicines for the treatment and prevention of all diseases.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector. www.globalhealthprogress.org;  twitter.com/globalhealth; facebook.com/pages/Global-Health-Progress/124850684219049;  linkedin.com/groups?home=&gid=2972068

Via EPR Network
More Healthcare press releases

A New Line of Weight Loss Psychology Books for Women

The New Year is coming, and people like to keep the resolutions they make. Symmetry Press offers help, with its new line ofweight-loss psychology books for women.

Psych Your Diet: A Daily Dose — 3 volumes   for  the 3 stages of weight loss—START, STICK TO IT, and KEEP IT OFF.

These are handy advice manuals for women to use every day. The books are designed to be read one piece at a time, one a day. Each selection gives an effective dose of daily knowhow, encouragement, and inspiration.

The research shows it is staying on a diet (adherence) and not the particular diet that makes for successful weight loss. 1,2,3 Women who want to lose weight need good information and help with adhering, just like they now have with knowing what to eat. Judging by the statistics, the old formula [diet + exercise = weight loss] is not helping women to adhere. On any given day 45% of women are dieting, but 62% of women from 20 to 74 are still overweight.

Breaking Up With Food: Maria’s Last Diet is a novel of passionate weight loss.

Via EPR Network
More Healthcare press releases

Global Health Progress Commends European Union and India Agreement Increasing Access to Drugs in Developing Countries

According to a Reuter’s article, the European Union (EU) and India have come to an agreement which should ease the process of exporting Indian drug manufacturers’medicines to developing countries, increasing these countries’ access to drugs.

Karel De Gucht, commissioner of the European Union (EU) has confirmed an agreement between the EU and India that will resolve some of the disputes that lead to the seizure of generic drugs in transit last year. This agreement will allow shipments of medication to pass through Europe to developing nations without being checked for anything except counterfeiting.

The new agreement will also amend custom codes allowing shipments of medications from India to reach countries located in South America via Europe. The confirmation comes amid trade talks between the EU and India.

Global Health Progress commends the agreements between the European Union and India, which will increase access to drugs, primarily generic medication, for underdeveloped countries. This process affects the affordability of generic medications to underdeveloped countries which fight the prominence of infectious diseases such as HIV/AIDS and malaria.

Since the 1960s, the philanthropic efforts of research-based biopharmaceuticalcompanies have worked to get medicines to the people that need them the most. In 2005, biopharmaceutical companies responded to requests with more than $3 billion in medical products donated worldwide.

Via EPR Network
More Healthcare press releases

What is the Best Way to Lose Weight? – One of the Topics that Inspired eMedToday

eMedToday is a new series of web sites that will address many health care issues, the first being, “What is the best way to lose weight ?” The site will be supervised by Graham Player, PhD who holds a Doctoral Degree in Health Science.

Graham Player PhD is the author of many books and internationally recognized for his work including “Everybody’s Health-Time to Reap the Benefits of East and West” and “Disease and Diagnosis for the Acupuncturist”. The web sites will be authoritative web sites that will contain content specifically chosen to help those who need information and solutions.

Weight loss is a problem of astronomical proportions in the U.S. alone. Nearly 64% of Americans are overweight and 325,000 deaths each year are directly related to obesity. The problem does not just concern adults; children are being affected as well. All of this has led to a multi-billion dollar weight loss industry.

eMedToday contains a variety of weight loss tools, tips and books all designed to provide the best information on “What is the best way to lose weight ?” In addition, the website will provide users with natural weight loss methods that include healthy food and exercise.

eMedToday will be launching the first website on weight loss but in the coming months there will be a variety of health topics in many areas including skin problems, heart problems, allergies, Alzheimer, diabetes and cancer.

eMedToday will be a trusted authority in the weight loss and other areas where people can access useful information.

Via EPR Network
More Healthcare press releases

Global Health Progress Applauds HIV-Prevention Medicine Trial, Encourages Access to Medicines in Developing Countries

The New England Journal of Medicine recently released the results of a ground-breaking trial of an HIV-prevention method called oral pre-exposure prophylaxis (PrEP). Data from the trial revealed an almost 44 percent reduction of new HIV infections among participants who took the antiretroviral tablet daily to prevent HIV, compared to those who took the placebo pill.

Participants in the study included 2,499 HIV-negative gay men, transgender women, and other men who have sex with men (MSM) from Peru, Ecuador, Brazil, South Africa, Thailand and the United States; these were randomly chosen to receive the antiretroviral (ARV) drug TDF/FTC (brand name Truvada) or a placebo pill. Regular HIV tests were administrated throughout the study. At the end of the trial, 36 participants who took Truvada had become infected, compared to 64 of the participants who took the placebo pill.

Similar trials are currently being conducted among heterosexuals in Africa and injection drug users in Thailand. Additionally, a trial of a similar ARV in gel form is currently being tested in three US cities, Pittsburgh, Boston and Birmingham, Alabama.

Global Health Progress is encouraged by the outcome of this trial, as it could lead to the prevention of HIV in developing countries and around the world. However, additional funding is needed not only to continue developing drugs like this, but to increase access to medicines around the world. As the world of medicine continues to advance, it is the responsibility of the entire international community to facilitate access to medicines. Success depends on all sectors working in partnership; not only to make medicines more accessible, but also to ensure continued innovation into new medicines for the treatment and prevention of all diseases.

Research-based biopharmaceutical companies help the fight against the HIV/AIDS epidemic by providing millions of doses of anti-retroviral drugs at discounted prices and, in some cases, for free to patients in developing countries. These donation programs for Least Developed Countries and sub-Saharan Africa, together with programs for lower and middle income countries, apply to more than 87 percent of all people living with HIV/AIDS worldwide.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector. www.globalhealthprogress.org; twitter.com/globalhealth;facebook.com/pages/Global-Health-Progress/124850684219049; linkedin.com/groups?home=&gid=2972068

Via EPR Network
More Healthcare press releases

International Clients Can Now Use A New Online Drugstore rxbuys.com By RX Corp

RX Corp is happy to invite new clients to an online pharmacy that has been launched recently and is ready to offer extremely beneficial prices on the most sought-for medicines like generic cialis.

From now on all customers wishing to pay reasonable price for top quality medications and secure an order within a short time frame can turn to rxbuys.com for good service. With emergence of this website new and regular customers will get more assortment, quicker service and full security guarantees. The most up-to-date technologies protect every customer from dishonesty and information pilfering. There are several methods of shipping and payment available that the client can choose from. All these things make this online pharmacy a real helping hand for everybody.

For an international visitor launching of rxbuys.com appears to be a nice alternative. Looking for a reliable, certified and reasonable pharmacy with quick and low-cost shipping terms such a customer can finally sigh with relief. Though rxbuys.com came into operation not long ago, new clients have already estimated it at its true worth for provision of high quality products and services. All the customers proved to be satisfied with regard to all other aspects of its operation. The wide range of medications that are always in stock will surprise even the most exacting customer and includes generic Viagra and Generic Cialis.

Via EPR Network
More Healthcare press releases

Psych Your Diet: A Daily Dose – The Handy Advice Manuals For Women To Use Every Day

Introducing a three-volume set of books about how to use psychology for weight-loss success. Together, the three volumes give women the help they need with the whole process of losing weight: how to START, how to STICK TO IT, how to KEEP IT OFF.

Authors
Dr. Kenneth Schwarz is a psychologist practicing in Connecticut, where he is on the allied health staff at Sharon Hospital. Julie North Schwarz is a writer in the field of women’s weight issues.

Also by the authors: Breaking Up With Food: Maria’s Last Diet, and Diet Tuffy: The Online System for Diet Mastery. They publish the Daily Blog at MariasLastDiet.com.

Product Details
Titles: Psych Your Diet: A Daily Dose
Volume 1. Psych Yourself to START
Volume 2. Psych Yourself to STICK TO IT
Volume 3. Psych Yourself to KEEP IT OFF
Release date: December 30, 2010
In paperback and multi-format e-book
Publisher: Symmetry Press LLC
Available at Amazon, Barnes & Noble, IndieBound, Apple, other online retailers, and at nearby bookstores.

Via EPR Network
More Healthcare press releases

Molplex Launches Novel ‘Drug Discovery On Demand’ Service

An innovative new online “drug discovery on demand” platform has been launched by Molplex, a company specializing in products and services for the life sciences. Designed to help drug discovery groups working anywhere in the world, it aims to eliminate the high start-up costs and minimize the financial risks traditionally associated with inventing new medicines.

Molplex CEO David Leahy said: “As the pharmaceutical industry changes, a new ecosystem of small, flexible teams operating as “Micro Pharmas” is emerging. Molplex will provide the services they need to succeed at inventing better medicines at lower cost”.

The first version of the new Molplex system launched today offers free access to sophisticated drug design systems, high quality assay-ready stock chemicals and high content biological screening at www.molplex.com.

Via EPR Network
More Healthcare press releases

Global Health Progress Amplifies New Report that Outlines Barriers in Securing Access to Medicines in Least Developed Countries

“There is a public health crisis in the least developed countries. It is a crisis made by humans and solvable only by humans. There is urgency for governments, businesses, NGOs and academia to collaborate in dealing with this most urgent of problems,” declares Cameron Institute’s new 200-page report, Pharmaceutical Access in Least Developed Countries: on-the-ground barriers and industry successes.

Executive Director D. Wayne Taylor, Ph.D., F.CIM., who prepared the report, cites the recent World Health Organization’s (WHO) Draft Global Plan and Strategy for Action in stressing the importance of pharmaceutical industry partnerships. The report states that the industry must focus its energies on “the growing burden of diseases and conditions that disproportionately affect developing countries, and particularly women and children.”

Global Health Progress actively supports the report’s outlined actions needed to solve this issue, including endorsement of public-private partnerships (PPPs), protecting intellectual property and drug patents as the cornerstones of affordable innovation, improving access to medicines and developing new drugs.

Public-private partnerships are one key way to improve access to medicines in the least developed countries. As the report notes, the research-based pharmaceutical industry, in various public-private partnerships, has been improving access to medicines in the least developed countries of the world since the 1950’s. To date, there have been 150 public-private partnerships whose aim it is to improve access to medicines and currently 90% of PPPs are industry-led.

Additionally, innovation is cited by the report as “the hallmark of the pharmaceutical industry. Without innovation there would be no immunizations,
medicines or biologics to save lives, improve quality of lives, and to save much needed healthcare dollars. A basic right in law is to retain possession of one’s own ideas and discoveries.” The report also notes the importance of protecting this innovation through intellectual property and drug patents, as well as through the infrastructure and legal structures needed for healthy growth.

The report adds that every dollar invested in new medicines relieves the healthcare system of seven dollars of expenditure elsewhere, and that new drugs increase life expectancy and life-time income by about 1.0% per year while also decreasing years of life lost. It also provides a summary of 2010 data regarding contributions provided by research-based pharmaceutical industry to least developed countries:

• USD 8,450,000,000 of product and investment
• 950,000,000 patients treated
• 9,500,000,000 doses/treatments administered
• 350,000 doctors, nurses and other health personnel trained

Despite this progress, actions are still needed to solve the problem without creating additional difficulties. For example, even though existing medicines for HIV/AIDS has reduced mortality rates in developed countries by 70%, adherence and compliance are two major obstacles, amongst many, to the successful deployment of these drugs in developing countries. Additional barriers to access and improved health in least-developed countries include “on the ground” barriers, such as market failure, corruption, non-existent health human resources and infrastructure, and the lack of both local and international political will.

Via EPR Network
More Healthcare press releases